Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Filings indexed 870 across all filing types
Latest filing 2025-08-22 Interim / Quarterly Rep…
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interim Results Announcement' for Namyue Holdings Limited for the six months ended 30 June 2025. It contains comprehensive unaudited financial statements, including the statement of profit or loss, statement of financial position, and detailed notes to the financial information. As it provides substantive financial data for an interim period rather than just an announcement of a report's availability, it is classified as an Interim/Quarterly Report. H2 2025
2025-08-22 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 95% confidence The document is an announcement listing the company’s board of directors and committee roles effective from a specified date, detailing changes in board composition and functions. This aligns with the category for announcements of changes in the company’s board or senior management.
2025-08-22 English
APPOINTMENT OF MEMBER OF NOMINATION COMMITTEE
Board/Management Information Classification · 87% confidence The document is a short announcement from Namyue Holdings Limited regarding the appointment of Ms. Li Jieyu to the Nomination Committee, effective 22 August 2025. It concerns changes in the company’s board/committee composition. This fits the ‘Board/Management Information’ category, code MANG.
2025-08-22 English
Terms of Reference of Nomination Committee
Governance Information Classification · 95% confidence The document is the Terms of Reference of the Nomination Committee for Namyue Holdings, detailing committee formation, composition, duties, authority, and governance procedures. It defines internal governance rules rather than announcing a meeting or financial results. This fits the definition of a Governance Information report (CGR).
2025-08-22 English
ANNOUNCEMENT IN RELATION TO DEALINGS IN SECURITIES OF A DIRECTOR DURING THE BLACK-OUT PERIOD
Director's Dealing Classification · 95% confidence The document is an announcement regarding the on-market disposal of shares by a non-executive director during a black-out period, reporting insider share dealings by Dr. Gu in compliance with Hong Kong Listing Rules Appendix C3. This fits the 'Director's Dealing' category.
2025-08-21 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 75% confidence The document is a notice of a board meeting date for approving interim results and considering an interim dividend. It does not present the financial results themselves (so it’s not an Interim/Quarterly Report or Earnings Release), nor does it disclose a change in board composition (so not MANG) or management share dealings. It’s a regulatory announcement of a corporate event without a specific category, so it falls into the general Regulatory Filings (RNS) fallback category.
2025-08-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.